These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1974201)

  • 1. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
    Cretton EM; Waterhous DV; Bevan R; Sommadossi JP
    Drug Metab Dispos; 1990; 18(3):369-72. PubMed ID: 1974201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
    Cretton EM; Xie MY; Bevan RJ; Goudgaon NM; Schinazi RF; Sommadossi JP
    Mol Pharmacol; 1991 Feb; 39(2):258-66. PubMed ID: 1996084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.
    Rajaonarison JF; Lacarelle B; De Sousa G; Catalin J; Rahmani R
    Drug Metab Dispos; 1991; 19(4):809-15. PubMed ID: 1680659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction and glucuronidation of naftazone by human and rat liver microsomes.
    Herber R; Hercelin B; Van Cantfort J; De Graeve J; Fournel-Gigleux S; Taguchi T; Magdalou J
    Drug Metab Dispos; 1995 Dec; 23(12):1305-14. PubMed ID: 8689937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
    Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; BĂ©langer A
    Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
    Stevens JC; Fayer JL; Cassidy KC
    Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucuronidation of 3'-azido-3'-deoxythymidine: human and rat enzyme specificity.
    Resetar A; Spector T
    Biochem Pharmacol; 1989 May; 38(9):1389-93. PubMed ID: 2719717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes.
    Magdalou J; Herber R; Bidault R; Siest G
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1166-73. PubMed ID: 1545383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of a beta-glucuronidase-resistant glucuronide conjugate of digitoxin by dog liver microsomes.
    Castle MC
    Drug Metab Dispos; 1993; 21(6):1147-50. PubMed ID: 7905397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferases.
    Alonen A; Aitio O; Hakala K; Luukkanen L; Finel M; Kostiainen R
    Drug Metab Dispos; 2005 May; 33(5):657-63. PubMed ID: 15689500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes.
    Chen M; Howe D; Leduc B; Kerr S; Williams DA
    Xenobiotica; 2007 Sep; 37(9):954-71. PubMed ID: 17896323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative metabolism of 3'-azido-3'-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys, and humans.
    Nicolas F; De Sousa G; Thomas P; Placidi M; Lorenzon G; Rahmani R
    Drug Metab Dispos; 1995 Mar; 23(3):308-13. PubMed ID: 7628294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.
    Rajaonarison JF; Lacarelle B; Catalin J; Durand A; Cano JP
    Drug Metab Dispos; 1993; 21(5):823-9. PubMed ID: 7902243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
    Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
    Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
    Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
    Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.